ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹401 Cr | ₹282 Cr | ₹358 Cr |
What is the latest Total Non-Current Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹401 Cr |
| Mar2024 | ₹282 Cr |
| Mar2023 | ₹358 Cr |
How is Total Non-Current Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹401 Cr | 42.00 | |
| Mar2024 | ₹282 Cr | -21.17 | |
| Mar2023 | ₹358 Cr | - | |
Compare Total Non-Current Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹13,171.6 Cr | -30% | -34% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -30% |
-34% |
|
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses